ChiCTR2100048549
Untitled Trial
An observational study on the safety and efficacy of Novel Coronavirus (COVID 19) vaccine in population with different characteristics
Ningbo First Hospital·Chinese Clinical Trial RegistryRecruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- Ningbo First Hospital
- Funder
- self raised
- Location
- China
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- Dec 31, 2022
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100048549
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100048549 through Pure Global AI's free database. This phase not specified trial is sponsored by Ningbo First Hospital and is currently Recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.